Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shangrong Wu
Observed name:
S. Wu
Institution:
Tianjin Medical University General Hospital
Observed institutions:
Tianjin Medical University General Hospital,
Fudan University Shanghai Cancer Center,
Second Hospital of Tianjin Medical University
ORCID:
0009-0003-0400-9272
Observed ORCID:
0009-0003-0400-9272
OpenAlex ID:
A5022640598
Prognostic value of GARS in bladder cancer and its role in the tumor microenvironment
2024
·
Kaifei Chen
, Shuaiqi Chen
, et al.
·
Translational Cancer Research
·
2
Comprehensive analysis of predictive factors for upstaging in intraprostatic cancer after radical prostatectomy: Different patterns of spread exist in lesions at different locations
2023
·
Shangrong Wu
, Yuchen Jiang
, et al.
·
Cancer Medicine
·
2
PDF
74P The safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab in patients (pts) with locally recurrent or metastatic triple-negative breast cancer (TNBC): A multi-cohort, phase II trial
2022
·
L. Liu
, L. Fan
, et al.
·
Immuno-Oncology Technology
·
1
PDF
Show more works
View as search
Works count:
3
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type